drugset
Drugs / trivalent inactivated influenza vaccine
last change Jan 2013 re-read 2 minutes ago

trivalent inactivated influenza vaccine

also known as TIV

Vaccine

Developed for
influenza
Investigated by
National Institute of Allergy and Infectious Diseases (NIAID) · Stanford University

Trials 1 · a red edge is where a trial was stopped

today NCT03022435 · Ph 4
201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT03022435 Oct 2012 → Jan 2013 influenza Stanford University Completed No outcome recorded

Evidence & citations 4 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as trivalent inactivated influenza vaccine “either the trivalent inactivated influenza vaccine (TIV) or intranasal live, attenuated influenza vaccine (LAIV).” NCT03022435 ↗
Known as TIV ClinicalTrials.gov intervention name — accepted as the source's own label NCT03022435 ↗
Modality Vaccine “Influenza Virus Vaccine Suspension for Intramuscular Injection” NCT03022435 ↗
Route Intramuscular “Influenza Virus Vaccine Suspension for Intramuscular Injection” NCT03022435 ↗